vs
ABVC BIOPHARMA, INC.(ABVC)与趣店(HTT)财务数据对比。点击上方公司名可切换其他公司
趣店的季度营收约是ABVC BIOPHARMA, INC.的1.4倍($1.1M vs $796.0K),趣店净利率更高(239.8% vs -256.6%,领先496.4%)
ABVC生物制药是一家处于临床阶段的生物制药企业,专注于开发肿瘤、眼科、中枢神经系统疾病等领域的创新治疗方案,业务覆盖北美及亚洲主要市场,多款自研候选药物正处于临床试验推进阶段。
趣店集团是中国本土金融科技服务提供商,核心业务涵盖小额消费信贷解决方案输出、风险管理技术服务及相关数字金融产品供应,主要服务国内广大年轻消费群体,业务布局集中于中国内地市场。
ABVC vs HTT — 直观对比
营收规模更大
HTT
是对方的1.4倍
$796.0K
净利率更高
HTT
高出496.4%
-256.6%
损益表 — Q3 FY2025 vs Q3 FY2024
| 指标 | ||
|---|---|---|
| 营收 | $796.0K | $1.1M |
| 净利润 | $-2.0M | $2.6M |
| 毛利率 | 100.0% | 11.1% |
| 营业利润率 | -246.8% | -121.7% |
| 净利率 | -256.6% | 239.8% |
| 营收同比 | 104.5% | — |
| 净利润同比 | -417.4% | — |
| 每股收益(稀释后) | $-0.09 | $0.01 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比,按日历期对齐,财年错位的公司也能正确匹配
营收
ABVC
HTT
| Q3 25 | $796.0K | — | ||
| Q4 24 | $2.0K | — | ||
| Q3 24 | $389.3K | $1.1M | ||
| Q2 24 | $117.1K | $1.0M | ||
| Q1 24 | $1.2K | $1.1M | ||
| Q4 23 | $2.2K | — | ||
| Q3 23 | $15.9K | $559.9K | ||
| Q2 23 | $6.1K | — |
净利润
ABVC
HTT
| Q3 25 | $-2.0M | — | ||
| Q4 24 | — | — | ||
| Q3 24 | $-394.8K | $2.6M | ||
| Q2 24 | $-942.3K | $1.9M | ||
| Q1 24 | $-2.8M | $-1.4M | ||
| Q4 23 | — | — | ||
| Q3 23 | $-3.3M | $-3.4M | ||
| Q2 23 | $-2.3M | — |
毛利率
ABVC
HTT
| Q3 25 | 100.0% | — | ||
| Q4 24 | 100.0% | — | ||
| Q3 24 | 99.9% | 11.1% | ||
| Q2 24 | 99.8% | 13.3% | ||
| Q1 24 | 77.0% | — | ||
| Q4 23 | — | — | ||
| Q3 23 | — | — | ||
| Q2 23 | — | — |
营业利润率
ABVC
HTT
| Q3 25 | -246.8% | — | ||
| Q4 24 | — | — | ||
| Q3 24 | -77.7% | -121.7% | ||
| Q2 24 | -734.2% | -107.6% | ||
| Q1 24 | -235539.8% | -129.9% | ||
| Q4 23 | — | — | ||
| Q3 23 | -13566.3% | -340.6% | ||
| Q2 23 | -35911.6% | — |
净利率
ABVC
HTT
| Q3 25 | -256.6% | — | ||
| Q4 24 | — | — | ||
| Q3 24 | -101.4% | 239.8% | ||
| Q2 24 | -804.4% | 187.1% | ||
| Q1 24 | -235203.2% | -131.8% | ||
| Q4 23 | — | — | ||
| Q3 23 | -20885.9% | -612.3% | ||
| Q2 23 | -37052.1% | — |
每股收益(稀释后)
ABVC
HTT
| Q3 25 | $-0.09 | — | ||
| Q4 24 | — | — | ||
| Q3 24 | $-0.03 | $0.01 | ||
| Q2 24 | $-0.08 | $0.01 | ||
| Q1 24 | $-0.29 | $-0.01 | ||
| Q4 23 | — | — | ||
| Q3 23 | $-0.82 | $-0.02 | ||
| Q2 23 | $-0.68 | — |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | ||
|---|---|---|
| 现金及短期投资手头流动性 | $257.2K | $104.9M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $12.1M | $225.2M |
| 总资产 | $21.2M | $246.8M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势,按日历期对齐
现金及短期投资
ABVC
HTT
| Q3 25 | $257.2K | — | ||
| Q4 24 | $313.1K | — | ||
| Q3 24 | $208.2K | $104.9M | ||
| Q2 24 | $200.0K | $112.8M | ||
| Q1 24 | $106.4K | $140.6M | ||
| Q4 23 | $139.5K | — | ||
| Q3 23 | $568.6K | $183.4M | ||
| Q2 23 | $176.1K | — |
股东权益
ABVC
HTT
| Q3 25 | $12.1M | — | ||
| Q4 24 | $1.2M | — | ||
| Q3 24 | $1.6M | $225.2M | ||
| Q2 24 | $1.8M | $217.5M | ||
| Q1 24 | $1.7M | $218.9M | ||
| Q4 23 | $1.6M | — | ||
| Q3 23 | $9.1M | $226.0M | ||
| Q2 23 | $-379.3K | — |
总资产
ABVC
HTT
| Q3 25 | $21.2M | — | ||
| Q4 24 | $7.5M | — | ||
| Q3 24 | $7.8M | $246.8M | ||
| Q2 24 | $8.0M | $227.9M | ||
| Q1 24 | $8.0M | $234.9M | ||
| Q4 23 | $7.8M | — | ||
| Q3 23 | $16.6M | $239.4M | ||
| Q2 23 | $9.3M | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | ||
|---|---|---|
| 经营现金流最新季度 | $-964.7K | — |
| 自由现金流经营现金流 - 资本支出 | — | — |
| 自由现金流率自由现金流/营收 | — | — |
| 资本支出强度资本支出/营收 | — | — |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势,按日历期对齐
经营现金流
ABVC
HTT
| Q3 25 | $-964.7K | — | ||
| Q4 24 | $-1.8M | — | ||
| Q3 24 | $60.2K | — | ||
| Q2 24 | $-211.4K | — | ||
| Q1 24 | $-955.8K | — | ||
| Q4 23 | $-4.2M | — | ||
| Q3 23 | $-1.4M | — | ||
| Q2 23 | $-899.8K | — |
自由现金流
ABVC
HTT
| Q3 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — | ||
| Q4 23 | $-4.2M | — | ||
| Q3 23 | — | — | ||
| Q2 23 | — | — |
自由现金流率
ABVC
HTT
| Q3 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — | ||
| Q4 23 | -194367.2% | — | ||
| Q3 23 | — | — | ||
| Q2 23 | — | — |
资本支出强度
ABVC
HTT
| Q3 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — | ||
| Q4 23 | 979.3% | — | ||
| Q3 23 | — | — | ||
| Q2 23 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图